Costa Rica's Medtech Shift: From Assembly Lines to Innovation Hubs

Jan de Vries · 2026-11-06

Costa Rica has long been known for manufacturing medical devices. But now, the country is making a strategic move: it's stepping up from making devices to engineering them. This shift could change how the medtech industry views the region—and it's worth paying attention to, especially if you're watching global trends in healthcare innovation. ### Why the shift matters For years, Costa Rica built a reputation as a reliable place for medical device manufacturing. Companies like Medtronic and Baxter have set up shop there, drawn by a skilled workforce and favorable business climate. But manufacturing alone isn't enough to stay competitive. So Costa Rica is investing in engineering, supplier networks, and digital capabilities. The goal? To attract higher-value medtech investment and move up the value chain. ### From assembly to R&D The transition isn't just about adding a few engineering jobs. It's about creating an ecosystem where innovation can thrive. That means fostering local talent, encouraging collaboration between universities and industry, and building infrastructure that supports research and development. It's a big bet, but one that could pay off handsomely. ### The digital push Digital health is a rapidly growing field, and Costa Rica wants a piece of the action. By expanding digital capabilities, the country aims to attract companies working on everything from telehealth to wearable devices. This aligns with global trends: medtech is becoming more connected, and countries that can offer digital expertise will have an edge. ### What this means for the global medtech industry For medtech companies looking to expand, Costa Rica offers a compelling proposition: a proven manufacturing base, now with growing engineering and digital capabilities. It's a one-stop shop for everything from design to production. And with the EU Inc proposal on the horizon—which aims to simplify cross-border incorporation for startups—companies might find it easier than ever to set up operations in Europe and beyond. > "Costa Rica is no longer just a place to build devices; it's becoming a place to innovate them," says a local industry expert. "That's a game-changer for the region." ### The road ahead Of course, challenges remain. Building an engineering hub takes time, and Costa Rica will need to compete with established players in the US and Europe. But the country's commitment to education and its track record of attracting foreign investment bode well. If successful, Costa Rica could become a model for other emerging markets looking to move up the medtech value chain. ### Bottom line Costa Rica's medtech bet is more than a news item—it's a signal. It shows that the global medtech landscape is evolving, and countries that invest in engineering and digital capabilities will be the ones that lead. For industry professionals, it's a reminder to keep an eye on emerging hubs. And for startups, it's a nudge to think globally, especially as initiatives like EU Inc make it easier to incorporate across borders. The future of medtech is not just about making devices; it's about engineering them—and Costa Rica is betting on that future.